Analyst Ratings for CalciMedica (CALC)
CALC Rating Summary
CALC Price Target Summary
- Highest: $10.00 (Oppenheimer)
- Lowest: $9.00 (Guggenheim)
- Average: $9.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.50 (+348.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$9.50 (+348.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Guggenheim | Vamil Divan | New Coverage | Buy (N/A) |
9.00 (N/A) |
0.64 (2.12) |
231.25% | Details |
| 1/29/2026 | H.C. Wainwright » Updated 8/13/2026 |
Joseph Pantginis | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.25 (2.12) |
69.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
